Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands
about
sameAs
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disordersGenetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease riskCost effectiveness analysis of different approaches of screening for familial hypercholesterolaemiaMortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality studyThe genetics and screening of familial hypercholesterolaemiaFamilial hypercholesterolemia: Review of diagnosis, screening, and treatmentCriteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab PopulationSubjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treatedThe panorama of familial hypercholesterolemia in Latin America: a systematic review.Quality assessment of the genetic test for familial hypercholesterolemia in the Netherlands.Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH RegistryUS physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.Inpatient detection of cardiac-inherited disease: the impact of improving family history takingTwo years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.Common genetic variants do not associate with CAD in familial hypercholesterolemia.Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)A genomewide search using an original pairwise sampling approach for large genealogies identifies a new locus for total and low-density lipoprotein cholesterol in two genetically differentiated isolates of Sardinia.Cascade Screening for Familial Hypercholesterolemia (FH)Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemiaHeterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.Genetics of coronary artery disease: discovery, biology and clinical translation.Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia.The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease.Familial hypercholesterolemia: current treatment and advances in management.Familial hypercholesterolemia: the lipids or the genes?Recent trends in lipid management: raising the bar and shifting the goalposts?Would raising the total cholesterol diagnostic cut-off from 7.5 mmol/L to 9.3 mmol/L improve detection rate of patients with monogenic familial hypercholesterolaemia?Patients' experiences and views of cascade screening for familial hypercholesterolemia (FH): a qualitative studyEstablished and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.Genetic testing of Korean familial hypercholesterolemia using whole-exome sequencing.Treatment of children with familial hypercholesterolemia.Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia.Detecting Germline PTEN Mutations Among At-Risk Patients With Cancer: An Age- and Sex-Specific Cost-Effectiveness AnalysisCascade testing in familial hypercholesterolaemia: how should family members be contacted?Management of hereditary dyslipidaemia; the paradigm of autosomal dominant hypercholesterolaemia.Reducing the burden of disease and death from familial hypercholesterolemia: a call to actionSystematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarctionRefinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.Familial hypercholesterolemia and the atherosclerotic disease.Economic evaluation of Cardio inCode®, a clinical-genetic function for coronary heart disease risk assessment
P2860
Q22330767-320CF880-91C6-449D-940C-A60B014A4AF4Q24322584-80066F00-15FC-4C90-A62D-A326284CE540Q24528552-9CD6C791-99C5-46CF-A68B-181FA40F3175Q24630340-CFA3C4D6-1601-47F7-BACF-57C12792ADDEQ26753081-846BE0D9-EFD1-49D1-B743-961B68586543Q26770143-DB15DB6A-0F43-4B25-8BE9-A0CF2DDE12A3Q27025178-3D52A357-6542-42F1-9758-D830FA166451Q28477200-B5736D1B-01A9-4454-8BE4-CFED4F87ACC7Q30244116-19B789F3-C4A6-4A3F-9DB6-D4144A943DD4Q30541806-D20ACF7E-2AE0-407C-BF28-3BC9C2128EB4Q31063192-0A22859E-99FF-4E3C-B959-1B7281ADCF07Q31133478-040A5732-2F76-4A12-BA13-0AA17114BD0AQ33166859-34174546-A4B4-4330-91E5-C8B76F5BC40FQ33532632-2420E0C8-DB57-4DDF-85A7-A4943559D4F2Q33620844-327A2D36-283E-4DF2-BA78-2632868B7817Q33630769-DA38FE6E-9805-40E9-A6CC-AE5550F5A6BBQ33910521-FAF3F2B6-F424-4BEB-867A-85CBE96B15CAQ33919782-64BBC681-492C-40E2-A31C-74BD7A649CAFQ34334828-C74A6919-32FC-467A-93D0-A3D591AFF1DDQ34499298-2DEB12CF-8CCC-451E-9252-32247A9E38ACQ34553141-2716DE72-79AA-45CE-8567-560799203A57Q34569742-BEF97869-DDF1-4982-933E-331B52AD2D82Q34579841-0E4053E5-4A2B-4334-81A0-72E49DD78371Q34769059-4FA599D1-ECAD-488C-8CB0-F768FB84CD18Q35014525-34568088-DEB8-4544-9D57-24B559DE09C9Q35072212-AE3E7C1C-C0EB-4B6B-B13D-4318420320C4Q35217153-0D5D4CF2-8EEE-4B36-B40A-C9F300E66BB9Q35549079-5A1336D5-D82A-4FDA-B46D-ECF36ECF8B6CQ35583268-4CCA51EA-ED9B-43FF-A211-932D27E63EB5Q35592865-BC66BFB6-6B16-49D5-B9BA-2F5E8047E07CQ35696538-FD8BDBDD-9448-49EA-BBF4-564EF49B283FQ35897064-ACBB4A07-1CB8-4001-AAD6-0AF62DD860DAQ35916640-2C0DD606-4A73-4D98-B952-53C91F5A2AEFQ36013242-D5F818B6-EB73-453F-B842-C44518AEF00FQ36270428-EA682F84-6B7F-49A9-B7BC-2F80FB4764BCQ36381467-8B0EBD77-2A1F-44EF-AC18-94B526739ADDQ36474966-DDB170EE-9547-4D00-B9BC-9330B8992E3CQ36966952-88447F3B-0D23-4462-B247-3173159CD3E3Q37029808-C2E6786F-740B-4F14-9623-8BAC674A9B5BQ37301010-0C724C03-6CEF-4EFD-BA76-E048F8D9262F
P2860
Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Review of first 5 years of scr ...... sterolaemia in the Netherlands
@ast
Review of first 5 years of scr ...... sterolaemia in the Netherlands
@en
Review of first 5 years of scr ...... sterolaemia in the Netherlands
@nl
type
label
Review of first 5 years of scr ...... sterolaemia in the Netherlands
@ast
Review of first 5 years of scr ...... sterolaemia in the Netherlands
@en
Review of first 5 years of scr ...... sterolaemia in the Netherlands
@nl
prefLabel
Review of first 5 years of scr ...... sterolaemia in the Netherlands
@ast
Review of first 5 years of scr ...... sterolaemia in the Netherlands
@en
Review of first 5 years of scr ...... sterolaemia in the Netherlands
@nl
P2093
P3181
P1433
P1476
Review of first 5 years of scr ...... sterolaemia in the Netherlands
@en
P2093
E J Sijbrands
J C Defesche
J J Kastelein
M A Umans-Eckenhausen
R L Scheerder
P3181
P356
10.1016/S0140-6736(00)03587-X
P407
P577
2001-01-20T00:00:00Z